Genetic epidemiology of moyamoya disease and CADASIL in over 120,000 healthy Korean individuals: Insights into cerebrovascular disorders
Open Access
- 22 September 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331174
Abstract
Background: East Asia has one of the highest global stroke burdens. Genetically, moyamoya disease (MMD) and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) contribute to this burden. This study investigated the allele frequencies and estimated the genetic prevalence of RNF213 and NOTCH3 variants in a large Korean population. Methods: Between July 2021 and August 2024, 129,933 individuals who underwent health checkups were included. RNF213 p.Arg4810Lys and three NOTCH3 variants, p.Arg544Cys, p.Arg640Cys, and p.Arg75Pro, were analyzed using next-generation sequencing. Allele frequencies were calculated, and genetic prevalence was estimated using the Hardy-Weinberg equilibrium. Results: The allele frequency of RNF213 p.Arg4810Lys was 1.08%, with 13 homozygotes. The estimated genetic prevalence of MMD was 1 in 47 individuals. For NOTCH3, the allele frequencies were 0.07% for p.Arg544Cys, 0.07% for p.Arg640Cys, and 0.04% for p.Arg75Pro, corresponding to an estimated genetic prevalence of CADASIL of 1 in 277 individuals. Eight individuals carried both the RNF213 and NOTCH3 variants. Conclusion: This large-scale study highlights the substantial genetic burden of RNF213 and NOTCH3 variants in Koreans, which partially contributes to the high stroke burden in East Asia. These findings emphasize the importance of population-specific genetic studies to optimize cerebrovascular disorder management in East Asia.Keywords
Funding Information
- National Research Foundation of Korea (2021R1C1C1005725)
This publication has 35 references indexed in Scilit:
- Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet Neurology, 2024
- The Genetic Basis of Moyamoya DiseaseTranslational Stroke Research, 2021
- Moyamoya Disease and Spectrums of RNF213 VasculopathyTranslational Stroke Research, 2019
- RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya DiseaseJournal of Stroke and Cerebrovascular Diseases, 2017
- Archetypal NOTCH3 mutations frequent in public exome: implications for CADASILAnnals of Clinical and Translational Neurology, 2016
- Intracranial arterial disease in CADASIL patientsJournal of the Neurological Sciences, 2015
- P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressureEnvironmental Health and Preventive Medicine, 2012
- Moyamoya disease: current concepts and future perspectivesThe Lancet Neurology, 2008
- Spectrum of Mutations in Biopsy-Proven CADASILArchives of Neurology, 2005
- Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patientsThe Lancet, 1997